About Avenue Therapeutics
Avenue Therapeutics is a company based in New York (United States) founded in 2015 was acquired by Cipla in November 2018.. The company has 2 employees as of December 31, 2024. Avenue Therapeutics has completed 1 acquisition, including Baergic Bio. Avenue Therapeutics offers products and services including AJ201, BAER-101, and IV Tramadol. Avenue Therapeutics operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter New York, United States
- Employees 2 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Avenue Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-11.65 M-12.29as on Dec 31, 2024
-
EBITDA
$-11.28 M22.4as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
2
as on Dec 31, 2024
- Investments & Acquisitions
-
Acquired by
Cipla
(Nov 13, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Avenue Therapeutics
Avenue Therapeutics is a publicly listed company on the OTC with ticker symbol ATXI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Avenue Therapeutics
Avenue Therapeutics offers a comprehensive portfolio of products and services, including AJ201, BAER-101, and IV Tramadol. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops treatments for neurologic diseases in the pipeline.
Innovative drug for addressing neurologic conditions effectively.
Specialty pharmaceutical for pain management in neurologic care.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Avenue Therapeutics
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(06 Jan 2017)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Post-IPO - Avenue Therapeutics | Valuation |
investors |
|
| Jan, 2017 | Amount | Debt – Conventional - Avenue Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Avenue Therapeutics
Avenue Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cipla. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs, generic drugs, and formulation services are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Avenue Therapeutics
Avenue Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Baergic Bio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Novel therapeutics for CNS disorders are developed and commercialized.
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Avenue Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avenue Therapeutics Comparisons
Competitors of Avenue Therapeutics
Avenue Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Avenue Therapeutics
Frequently Asked Questions about Avenue Therapeutics
When was Avenue Therapeutics founded?
Avenue Therapeutics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Avenue Therapeutics located?
Avenue Therapeutics is headquartered in New York, United States. It is registered at New York, New York, United States.
How many employees does Avenue Therapeutics have?
As of Dec 31, 2024, the latest employee count at Avenue Therapeutics is 2.
What does Avenue Therapeutics do?
Avenue Therapeutics, a Fortress Biotech Company, is a specialty pharmaceutical company that acquiresin-licenses, develops and commercializes products principally for use in the acutehospital setting. Its initial product candidate is an intravenous (IV) formulation of tramadol HCI for the treatment of moderate to moderately severe post-operative pain. Tramadol is a synthetic dual-acting opioid and centrally acting analgesic with weak opioid agonist properties.
Who are the top competitors of Avenue Therapeutics?
Avenue Therapeutics's top competitors include Flexion Therapeutics, Cara Therapeutics and Trevena.
What products or services does Avenue Therapeutics offer?
Avenue Therapeutics offers AJ201, BAER-101, and IV Tramadol.
Is Avenue Therapeutics publicly traded?
Yes, Avenue Therapeutics is publicly traded on OTC under the ticker symbol ATXI.
How many acquisitions has Avenue Therapeutics made?
Avenue Therapeutics has made 1 acquisition, including Baergic Bio.
Who are Avenue Therapeutics's investors?
Avenue Therapeutics has 1 investor. Key investors include Cipla.
What is Avenue Therapeutics's ticker symbol?
The ticker symbol of Avenue Therapeutics is ATXI on OTC.